InsiderTrades

Form 4 for NHC NATIONAL HEALTHCARE CORP

Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-22 · accession 0001437749-24-005581 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-26 2024-02-22 NHC Dodson Vicki L Sr.VP Patient Srvcs F - Tax $100.76 -2,811 4,831 -37% -$283.2K
D 2024-02-26 2024-02-22 NHC Dodson Vicki L Sr.VP Patient Srvcs M - OptEx $63.96 +3,733 7,642 +96% +$238.8K
D 2024-02-26 2024-02-22 NHC Dodson Vicki L Sr.VP Patient Srvcs M - OptEx $0.00 -3,733 3,734 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Shares of Common Stock held in my name 2024-02-22 F D 2,811 $100.76 4,830.55 D — — (F2) Shares were withheld by the Company to pay the exercise price and withholding tax obligations. (F3) Total amount of shares beneficially owned following transactions reported on this form.
2 Common Shares of Common Stock held in my name 2024-02-22 M A 3,733 $63.96 7,641.55 D — — (F1) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
3 Derivative Option to Purchase Common Stock 2024-02-22 M D 3,733 $0.00 3,734 D $63.96 · 2023-02-18 to 2027-02-18 7,467 Common Stock (F1) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).